Elanco Animal Health

ELANNYSE United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$11.207 B

$22.43 +0.04%

Close of 21 Sept 2026

Revenue

$4.71B

#705 by revenue

Earnings

-$232.0M

Loss-making

Shares outstanding

499,621,830

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#30Corcept TherapeuticsCORT$12.3B
#31Madrigal PharmaceuticalsMDGL$12.1B
#32Elanco Animal HealthELAN$11.2B
#33Axsome TherapeuticsAXSM$10.8B
#34Dr Reddys LaboratoriesRDY$10.3B

Insiders buying

All insider buying →

5 open-market purchases by officers and directors of Elanco Animal Health, worth $1.47M. Grants and option exercises are excluded.

Lawrence Erik Kurzius$935.9K
40,000 shares at $23.40 on 20 Aug 2026 · filed 21 Aug 2026
Shiv O'NeillGC AND CORP SEC$94.3K
3,998 shares at $23.58 on 18 Aug 2026 · filed 18 Aug 2026
Michael J. Harrington$109.1K
5,000 shares at $21.82 on 12 Aug 2026 · filed 13 Aug 2026
Paul Herendeen$236.8K
10,000 shares at $23.69 on 7 Aug 2026 · filed 10 Aug 2026
Robert M. VanhimbergenEVP and CFO$96.9K
4,200 shares at $23.08 on 7 Aug 2026 · filed 10 Aug 2026

What if Elanco Animal Health were worth as much as…

Open the what-if tool →

Gold $30.3T

$60,593.94

Per share 2,701× higher

Bitcoin $1.72T

$3,442.21

Per share 153× higher

Nvidia $5.48T

$10,968.01

Per share 489× higher

Or at a round number

$20.0B $50.0B $100.0B $200.0B

Where these numbers come from

Share counts and financials for Elanco Animal Health are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 22 Sept 2026. Read the methodology.